Percutaneous Myocardial Laser Developer Drafts IDE Agreement With FDA
This article was originally published in The Gray Sheet
Executive Summary
CardioGenesis will meet with FDA by year-end to finalize a clinical trial protocol to support PMA approval of its Axcis laser percutaneous myocardial channeling (PMC) system for treating severe angina